Overview of Rpl14p3: A Non-Coding RNA Molecule with Potential as A Drug Target

Target Name: RPL14P3

NCBI ID: G730747

RPL14P3

Other Name(s): RPL14_2_522 | ribosomal protein L14 pseudogene 3 | Ribosomal protein L14 pseudogene 3

Overview of Rpl14p3: A Non-Coding RNA Molecule with Potential as A Drug Target

Rpl14p3 (RPL14_2_522) is a non-coding RNA molecule that has been identified as a potential drug target and biomarker for various diseases, including cancer, neurodegenerative diseases, and psychiatric disorders. Its unique structure and function have made it an attractive target for researchers to investigate, and numerous studies have demonstrated its involvement in various cellular processes. In this article, we will provide an overview of Rpl14p3, including its structure, function, and potential as a drug target.

Structure

Rpl14p3 is a small non-coding RNA molecule that consists of 231 amino acid residues. It has a unique structure, with a length of 194 amino acids and a single exon. The molecule has a left-handed preference, which means that the first amino acid residue is in the left side and the last amino acid residue is in the right side of the molecule.

Function

Rpl14p3 is involved in various cellular processes, including cell growth, apoptosis, and transcriptional regulation. It has been shown to play a role in cell proliferation, where it can promote the growth of cancer cells and contribute to their survival. Rpl14p3 has also been involved in regulating cell apoptosis, which is the process by which cells die naturally. It has been shown to induce apoptosis in various cell types, including cancer cells, neurons, and microglia.

In addition to its role in cell apoptosis, Rpl14p3 has also been shown to regulate gene expression. It has been shown to interact with various transcription factors, including DNMT1, which is a DNA methyltransferase that plays a role in gene repression. Rpl14p3 has also been shown to play a role in the regulation of microRNA (miRNA) levels, which are small non-coding RNAs that play a critical role in post-transcriptional gene regulation.

Potential as a Drug Target

Rpl14p3 has great potential as a drug target due to its unique structure and function. Its involvement in cell proliferation, apoptosis, and transcriptional regulation make it an attractive target for small molecules that can modulate these processes. Additionally, its role in regulating gene expression and miRNA levels also makes it a potential target for drugs that can modulate gene function.

One of the main advantages of Rpl14p3 as a drug target is its accessibility. Its small size and single exon make it easy to manipulate, and its left-handed preference makes it more stable and less prone to errors during transcription. This makes it an attractive target for small molecules that can modulate its function.

Another advantage of Rpl14p3 as a drug target is its diverse functions. Its involvement in various cellular processes makes it an attractive target for drugs that can modulate its function in a variety of ways. This makes it a more versatile target than some other potential drug targets.

Conclusion

Rpl14p3 is a non-coding RNA molecule that has a unique structure and function. Its involvement in various cellular processes, including cell growth, apoptosis, and transcriptional regulation, make it an attractive target for small molecules that can modulate its function. Additionally, its accessibility and diversity make it a more versatile target than some other potential drug targets. Further research is needed to fully understand the role of Rpl14p3 as a drug target and its potential as a biomarker for various diseases.

Protein Name: Ribosomal Protein L14 Pseudogene 3

The "RPL14P3 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about RPL14P3 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets